31. Burchell A. N., Coutlée F., Tellier P. P., Hanley J., Franco E. L. Genital transmission of human papillomavirus in recently formed heterosexual couples.
32. Centers for Disease Control and Prevention. 2008 through 2017 adolescent HPV vaccination coverage trend report. Available at: https://www.cdc.gov/vaccines/imz-managers/coverage/teenvaxview/data-reports/hpv/trend/index.html. Accessed May 4, 2019.
33. Oliver S. E., Unger E. R., Lewis R., McDaniel D., Gargano J. W., Steinau M., Markowitz L. E. Prevalence of human papillomavirus among females after vaccine introduction-National Health and Nutrition Examination Survey, United States, 2003–2014.
34. McClung N. M., Gargano J. W., Park I. U., et al. Estimated number of cases of high-grade cervical lesions diagnosed among women – United States, 2008 and 2016.
35. Andersson L. RETRACTED: increased incidence of cervical cancer in Sweden: possible link with HPV vaccination.
36. Motta M., Callaghan T., Sylvester S. Knowing less but presuming more: Dunning-Kruger effects and the endorsement of anti-vaccine policy attitudes.
37. Betsch C., Renkewitz F., Betsch T., Ulshöfer C. The Influence of Vaccine-critical Websites on Perceiving Vaccination Risks.
38. Ogilvie G. S., Phan F., Pedersen H. N., Dobson S. R., Naus M., Saewyc E. M. Population-level sexual behaviours in adolescent girls before and after introduction of the human papillomavirus vaccine (2003–2013).
39. Gee J., Naleway A., Mittendorf K., Irving S., Henninger M., Crane B., Smith N., Daley M. Incidence of primary ovarian insufficiency following adolescent vaccination. Presented at 32nd Annual International Papillomavirus Conference, October 2018, Sydney, Australia.
40. Gee J., Arana J. Postural orthostatic tachycardia syndrome after human papillomavirus vaccination. Presented at 32nd Annual International Papillomavirus Conference, October 2018, Sydney, Australia.
1. Lee K. C., Ladizinski B. The clap heard round the world.
2. Bierman W., Levenson C. L. The treatment of gonorrhea arthritis by means of systemic and additional focal heating.
3. Golden M. R., Whittington W. L., Handsfield H. H., Hughes J. P., Stamm W. E., Hogben M., Clark A., Malinski C., Helmers J. R., Thomas K. K., Holmes K. K. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.
4. Wolfheiler D., Potterat J. J. How do sexual networks affect HIV/STD prevention? Available at http://caps.ucsf.edu/uploads/pubs/FS/pdf/networksFS.pdf. Accessed May 20, 2015.
5. Potterat J. J.
6. Morris M. Sexual networks and HIV.
7. Centers for Disease Control and Prevention. STDs in racial and ethnic minorities. Available at: http://www.cdc.gov/std/stats14/minorities.htm. Accessed June 20, 2016.
8. Sanders S. A., Reece M., Herbenick D., Schick V., Dodge B., Fortenberry J. D. Condom use during most recent vaginal intercourse event among a probability sample of adults in the United States.
9. Trujillo L., Chapin-Bardales J., German E. J., Kanny D., Wejnert C. Trends in sexual risk behaviors among Hispanic/Latino Men who have sex with men—19 urban areas, 2011–2017.
10. Rosenberg E. S., Khosropour C. M., Sullivan P. S. High prevalence of sexual concurrency and concurrent unprotected anal intercourse across racial/ethnic groups among a national, web-based study of men who have sex with men in the United States.
11. Stenger M. R., Bauer H., Torrone E., et al. Denominators matter: trends in Neisseria gonorrhoeae incidence among gay, bisexual and other men who have sex with men (GBMSM) in the U.S. – findings from the STD Surveillance Network (SSuN) 2010–2013.